US pharmaceutical company Eli Lilly and Co recently announced a roughly $200 million expansion of its manufacturing site in ...

Eli Lilly logo is shown on one of the company's ... selling blood sugar-regulating medicine. According to the International Diabetes Federation, China has about 140 million individuals diagnosed ...

Prior to his appearance at a major London conference, John Grumitt, vice president, International Diabetes Federation (IDF), speaks to pharmaphorum about how the organisation is working to improve ...

As global populations age, the prevalence of type 2 diabetes and its associated complications, such as sarcopenia, continues to rise. Sarcopenia, which involves the progressive decline of muscle ...

The "Biopharmaceuticals Contract Manufacturing - Market Insights, Competitive Landscape, Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The biopharmaceuticals contract ...

It may be time to add Covid-19 infection to the list of possible risk factors for developing type 2 diabetes at a young age. An observational study published Monday in JAMA Network Open found ...

Diabetes affects more than five million people in Britain – that’s one in every 14 of us – with around 90 per cent of those living with type 2 diabetes. Yet in spite of so many having the ...

Groundbreaking research presented at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that could significantly reduce or even eliminate the need for insulin therapy.

About the Phase 3 DIAMOND Program of OCS-01 in Diabetic Macular Edema ...

After years of struggle, patients with diabetes have won major victories for access to affordable insulin, but the fight is not over.

Oct. 9, 2024 — People with a preference for sweets are at a higher risk of developing depression, diabetes, and suffering a stroke, according to new ... How Diabetes-Risk Genes Make Cells Less ...